Related Experiment Videos
A new transthyretin variant--ATTR Arg104Cys
Summary
Genetic analysis identified a new transthyretin variant (TTR R104C) in a patient with peripheral neuropathy. This specific mutation may be rare and its disease association requires further investigation.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Peripheral neuropathies can be caused by genetic factors, including transthyretin (TTR) gene mutations.
- Mutation scanning techniques like single-strand conformation polymorphism (SSCP) analysis are used to detect genetic variations.
Observation:
- A transthyretin variant was detected in a patient presenting with peripheral neuropathy.
- The patient exhibited sensory axonal neuropathy without upper limb or autonomic nervous system involvement.
- No amyloid deposition was observed in biopsies, and no family history of amyloidosis was reported.
Findings:
- Genetic characterization revealed a thymine to cytosine substitution at nucleotide position 299 in the TTR gene.
- This substitution results in an arginine to cysteine replacement at position 104 (TTR R104C) of the transthyretin protein.
- Both DNA sequencing and restriction fragment length polymorphism (RFLP) analysis confirmed the TTR R104C mutation.
Implications:
- The TTR R104C mutation's role in peripheral neuropathy requires further study.
- This specific transthyretin variant may be rare, necessitating the identification of additional cases to establish a definitive disease association.
- Understanding genotype-phenotype correlations in transthyretin-related neuropathies is crucial for diagnosis and management.